Drug Approval | September 21, 2023
USFDA conducts inspection at InvaGen manufacturing facility in Central Islip, NY, USA
InvaGen has received 5 inspectional observations in Form 483
InvaGen has received 5 inspectional observations in Form 483
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
Apollo Telehealth has established more than 700 centers, in 7 states
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
The hospital in association with ‘We Warriors’ and ‘Dev Bhumi Rakshak Foundation’ organized First Aid and CPR training session for youngsters and volunteers
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
The companies will spread the adoption of the latest HOS and Mass Spec technologies to help scientists improve the safety, stability, and effectiveness of biotherapeutics
Subscribe To Our Newsletter & Stay Updated
